MS

Morgan Stanley
D

MS

Arincen79/100B

Morgan Stanley return on equity (ROE)

Morgan Stanley's return on equity is 17.66%: net income of 20.68B USD over the last twelve months on shareholders' equity of 117.11B USD.

Today
17.66%
Average, 5 years
12.92%
Low, 5 years
9.32%
High, 5 years
17.66%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 20.68B ÷ 117.11B = 17.66%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

What drives Morgan Stanley's return on equity?

Net margin
25.6%
profit on each dollar of sales
Asset turnover
0.05×
sales on each dollar of assets
Equity multiplier
12.72×
assets on each dollar of equity
Return on equity
15.1%
FY2025
  • FY202525.6% × 0.05 × 12.72 = 15.1%
  • FY202423.2% × 0.05 × 11.63 = 12.8%
  • FY202317.9% × 0.04 × 12.05 = 9.2%
  • FY202222.0% × 0.04 × 11.79 = 11.0%
  • FY202126.6% × 0.05 × 11.27 = 14.3%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today17.66%20.68B117.11B
FY202531 Dec 202515.10%16.86B111.63B
FY202431 Dec 202412.95%13.53B104.51B
FY202331 Dec 20239.18%9.09B99.04B
FY202231 Dec 202211.16%11.18B100.14B
FY202131 Dec 202114.34%15.12B105.44B
FY202031 Dec 202010.98%11.18B101.78B
FY201931 Dec 201911.33%9.24B81.55B
FY201831 Dec 201811.07%8.88B80.25B
FY201731 Dec 20178.03%6.22B77.39B
FY201631 Dec 20168.05%6.12B76.05B
FY201531 Dec 20158.35%6.28B75.18B
FY201431 Dec 20145.17%3.67B70.90B
FY201331 Dec 20135.48%3.61B65.92B
FY201231 Dec 20121.15%716.00M62.11B
FY201131 Dec 20117.49%4.65B62.05B
FY201031 Dec 20109.97%5.70B57.21B
FY200931 Dec 20093.01%1.41B46.69B
FY200831 Dec 20083.50%1.71B48.75B
FY200730 Nov 200710.26%3.21B31.27B
FY200630 Nov 200621.13%7.47B35.36B
FY200530 Nov 200516.92%4.94B29.18B
FY200430 Nov 200415.90%4.49B28.21B
FY200330 Nov 200315.23%3.79B24.87B
FY200230 Nov 200213.65%2.99B21.89B
FY200130 Nov 200117.00%3.52B20.72B
FY200030 Nov 200028.31%5.46B19.27B
FY199930 Nov 199928.16%4.79B17.01B
FY199830 Nov 199821.86%3.39B15.52B
FY199730 Nov 199717.29%2.59B14.96B
FY199631 Dec 199618.42%951.40M5.16B
FY199531 Dec 199517.72%856.40M4.83B
FY199431 Dec 199418.04%740.90M4.11B
FY199331 Dec 199317.36%603.60M3.48B
FY199231 Jan 199314.87%510.50M3.43B
FY199131 Dec 199115.87%475.10M2.99B
FY199031 Dec 199012.45%270.40M2.17B
FY198931 Dec 198921.92%443.00M2.02B
FY198831 Dec 198829.50%394.60M1.34B
FY198731 Dec 198723.08%230.90M1.00B
FY198631 Dec 198625.62%201.30M785.60M
FY198531 Dec 198535.05%105.90M302.10M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Morgan Stanley's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.